TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs4846483
log Bayes Factor = <0.0001
Chromosome 1   position 218,632,368  (GRCh37) Explore rs4846483 on Ensembl!
Variant rs4846483 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
S40.9 Superficial injury of shoulder and upper arm, unspecified
0.033 0.967 0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.970 0.030
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.971 0.029
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.972 0.028
T39.1 4-Aminophenol derivatives
0.000 0.974 0.026
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.974 0.026
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.975 0.025
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.975 0.025
C78.0 Secondary malignant neoplasm of lung
0.025 0.975 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.000 0.975 0.025
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.975 0.025
C78.7 Secondary malignant neoplasm of liver
0.025 0.975 0.000
T40.2 Other opioids
0.000 0.975 0.025
T43.2 Other and unspecified antidepressants
0.000 0.977 0.023
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.977 0.023
T40.6 Other and unspecified narcotics
0.000 0.977 0.023
C78 Secondary malignant neoplasm of respiratory and digestive organs
0.023 0.977 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.977 0.022
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.978 0.022
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.978 0.022
T39.4 Antirheumatics, not elsewhere classified
0.000 0.978 0.021
T39.2 Pyrazolone derivatives
0.000 0.978 0.021
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.979 0.021
T43.6 Psychostimulants with abuse potential
0.000 0.979 0.021
C78.1 Secondary malignant neoplasm of mediastinum
0.020 0.980 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.980 0.020
J95.8 Other postprocedural respiratory disorders
0.000 0.980 0.020
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.980 0.020
T39.0 Salicylates
0.000 0.980 0.020
C78.4 Secondary malignant neoplasm of small intestine
0.019 0.981 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.981 0.019
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.981 0.019
T40.8 Lysergide [LSD]
0.000 0.981 0.019
T40.7 Cannabis (derivatives)
0.000 0.981 0.019
T40.3 Methadone
0.000 0.981 0.019
T40.1 Heroin
0.000 0.981 0.019
T40.0 Opium
0.000 0.981 0.019
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.981 0.019
T36 Poisoning by systemic antibiotics
0.000 0.981 0.019
T50.8 Diagnostic agents
0.000 0.982 0.018
T50.7 Analeptics and opioid receptor antagonists
0.000 0.982 0.018
T50.5 Appetite depressants
0.000 0.982 0.018
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.982 0.018
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.982 0.018
T50.1 Loop [high-ceiling] diuretics
0.000 0.982 0.018
T50.0 Mineralocorticoids and their antagonists
0.000 0.982 0.018
T43.9 Psychotropic drug, unspecified
0.000 0.982 0.018
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.982 0.018
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.982 0.018
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.982 0.018
T40.5 Cocaine
0.000 0.982 0.018
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.982 0.018
L02.2 Cutaneous abscess, furuncle and carbuncle of trunk
0.018 0.982 0.000
T42.0 Hydantoin derivatives
0.000 0.982 0.018
T50.4 Drugs affecting uric acid metabolism
0.000 0.982 0.018
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.982 0.018
T40.4 Other synthetic narcotics
0.000 0.982 0.018
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.982 0.018
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.983 0.017
T42.4 Benzodiazepines
0.000 0.983 0.017
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.983 0.017
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.983 0.017
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.983 0.017
T42.1 Iminostilbenes
0.000 0.983 0.017
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.984 0.016
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.984 0.016
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.984 0.016
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.984 0.016
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.984 0.016
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.984 0.016
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.984 0.016
T44.0 Anticholinesterase agents
0.000 0.984 0.016
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.984 0.016
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.984 0.016
T42.3 Barbiturates
0.000 0.984 0.016
T42.2 Succinimides and oxazolidinediones
0.000 0.984 0.016
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs
0.016 0.984 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.984 0.016
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.984 0.016
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.984 0.016
T37.5 Antiviral drugs
0.000 0.984 0.016
T37.4 Anthelminthics
0.000 0.984 0.016
T37.3 Other antiprotozoal drugs
0.000 0.984 0.016
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.984 0.016
T37.1 Antimycobacterial drugs
0.000 0.984 0.016
T37.0 Sulphonamides
0.000 0.984 0.016
N81.3 Complete uterovaginal prolapse
0.015 0.985 0.000
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs
0.015 0.985 0.000
T36.0 Penicillins
0.000 0.985 0.015
T41.5 Therapeutic gases
0.000 0.985 0.014
T41.4 Anaesthetic, unspecified
0.000 0.985 0.014
T41.3 Local anaesthetics
0.000 0.985 0.014
T41.2 Other and unspecified general anaesthetics
0.000 0.985 0.014
T41.1 Intravenous anaesthetics
0.000 0.985 0.014
T41.0 Inhaled anaesthetics
0.000 0.985 0.014
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum
0.014 0.986 0.000
S40 Superficial injury of shoulder and upper arm
0.014 0.986 0.000
T36.9 Systemic antibiotic, unspecified
0.000 0.986 0.014
T36.8 Other systemic antibiotics
0.000 0.986 0.014
T36.7 Antifungal antibiotics, systemically used
0.000 0.986 0.014
T36.6 Rifamycins
0.000 0.986 0.014
T36.5 Aminoglycosides
0.000 0.986 0.014
T36.2 Chloramphenicol group
0.000 0.986 0.014
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.986 0.014
T45.0 Antiallergic and antiemetic drugs
0.000 0.986 0.014
T38.1 Thyroid hormones and substitutes
0.000 0.986 0.013
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.987 0.013
T49.9 Topical agent, unspecified
0.000 0.987 0.013
T49.8 Other topical agents
0.000 0.987 0.013
T49.7 Dental drugs, topically applied
0.000 0.987 0.013
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.987 0.013
T49.5 Ophthalmological drugs and preparations
0.000 0.987 0.013
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.987 0.013
T49.3 Emollients, demulcents and protectants
0.000 0.987 0.013
T49.2 Local astringents and local detergents
0.000 0.987 0.013
T49.1 Antipruritics
0.000 0.987 0.013
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.987 0.013
T48.5 Anti-common-cold drugs
0.000 0.987 0.013
T48.4 Expectorants
0.000 0.987 0.013
T48.3 Antitussives
0.000 0.987 0.013
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.987 0.013
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.987 0.013
T48.0 Oxytocic drugs
0.000 0.987 0.013
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.987 0.013
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.987 0.013
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.987 0.013
T46.7 Peripheral vasodilators
0.000 0.987 0.013
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.987 0.013
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.987 0.013
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.987 0.013
T36.3 Macrolides
0.000 0.987 0.012
C78.5 Secondary malignant neoplasm of large intestine and rectum
0.012 0.988 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.988 0.012
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.988 0.012
T47.7 Emetics
0.000 0.988 0.012
T47.6 Antidiarrhoeal drugs
0.000 0.988 0.012
T47.5 Digestants
0.000 0.988 0.012
T47.4 Other laxatives
0.000 0.988 0.012
T47.3 Saline and osmotic laxatives
0.000 0.988 0.012
T47.2 Stimulant laxatives
0.000 0.988 0.012
T36.4 Tetracyclines
0.000 0.988 0.012
T46.1 Calcium-channel blockers
0.000 0.988 0.012
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.988 0.012
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.988 0.012
T38.9 Other and unspecified hormone antagonists
0.000 0.988 0.012
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.988 0.012
T38.7 Androgens and anabolic congeners
0.000 0.988 0.012
T38.5 Other oestrogens and progestogens
0.000 0.988 0.012
T38.4 Oral contraceptives
0.000 0.988 0.012
T38.2 Antithyroid drugs
0.000 0.988 0.012
T38.0 Glucocorticoids and synthetic analogues
0.000 0.988 0.012
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.988 0.012
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.988 0.012
T45.8 Other primarily systemic and haematological agents
0.000 0.988 0.012
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.988 0.012
T45.6 Fibrinolysis-affecting drugs
0.000 0.988 0.012
T45.4 Iron and its compounds
0.000 0.988 0.012
T45.3 Enzymes, not elsewhere classified
0.000 0.988 0.012
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.989 0.011
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.989 0.011
C78.2 Secondary malignant neoplasm of pleura
0.011 0.989 0.000
T47.0 Histamine H(2)-receptor antagonists
0.000 0.989 0.010
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.989 0.010
O72.1 Other immediate postpartum haemorrhage
0.010 0.990 0.000
T45.2 Vitamins, not elsewhere classified
0.000 0.990 0.010
S40.8 Other superficial injuries of shoulder and upper arm
0.010 0.990 0.000
S40.7 Multiple superficial injuries of shoulder and upper arm
0.010 0.990 0.000
S40.0 Contusion of shoulder and upper arm
0.009 0.991 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.000 0.991 0.009
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.991 0.009
R68.8 Other specified general symptoms and signs
0.009 0.991 0.000
T45.5 Anticoagulants
0.000 0.991 0.009
M54.39 Sciatica (Site unspecified)
0.009 0.991 0.000
E04.2 Non-toxic multinodular goitre
0.000 0.992 0.008
L02 Cutaneous abscess, furuncle and carbuncle
0.008 0.992 0.000
G93.3 Postviral fatigue syndrome
0.008 0.992 0.000
J44.9 Chronic obstructive pulmonary disease, unspecified
0.000 0.992 0.008
O82.0 Delivery by elective Caesarean section
0.007 0.993 0.000
K92.1 Melaena
0.007 0.993 0.000
J95 Postprocedural respiratory disorders, not elsewhere classified
0.000 0.993 0.007
L02.4 Cutaneous abscess, furuncle and carbuncle of limb
0.007 0.993 0.000
K83.8 Other specified diseases of biliary tract
0.000 0.993 0.007
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.001 0.994 0.006
C83.3 Large cell (diffuse)
0.006 0.994 0.000
L02.3 Cutaneous abscess, furuncle and carbuncle of buttock
0.006 0.994 0.000
L02.9 Cutaneous abscess, furuncle and carbuncle, unspecified
0.006 0.994 0.000
Z83.7 Family history of diseases of the digestive system
0.000 0.994 0.006
L02.8 Cutaneous abscess, furuncle and carbuncle of other sites
0.006 0.994 0.000
G55.2 Nerve root and plexus compressions in spondylosis
0.000 0.994 0.006
Z42.0 Follow-up care involving plastic surgery of head and neck
0.000 0.994 0.006
J43.9 Emphysema, unspecified
0.000 0.995 0.005
J95.5 Postprocedural subglottic stenosis
0.000 0.995 0.005
J95.4 Mendelson's syndrome
0.000 0.995 0.005
J95.3 Chronic pulmonary insufficiency following surgery
0.000 0.995 0.005
J95.2 Acute pulmonary insufficiency following nonthoracic surgery
0.000 0.995 0.005
J95.1 Acute pulmonary insufficiency following thoracic surgery
0.000 0.995 0.005
J95.9 Postprocedural respiratory disorder, unspecified
0.000 0.995 0.005
C83 Diffuse non-Hodgkin's lymphoma
0.005 0.995 0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.005 0.995 0.000
L02.1 Cutaneous abscess, furuncle and carbuncle of neck
0.005 0.995 0.000
J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection
0.000 0.995 0.005
R68 Other general symptoms and signs
0.005 0.995 0.000
C83.1 Small cleaved cell (diffuse)
0.005 0.995 0.000
R68.2 Dry mouth, unspecified
0.005 0.995 0.000
L02.0 Cutaneous abscess, furuncle and carbuncle of face
0.005 0.995 0.000
T88 Other complications of surgical and medical care, not elsewhere classified
0.000 0.995 0.005
T88.6 Anaphylactic shock due to adverse effect of correct drug or medicament properly administered
0.000 0.995 0.005
T88.8 Other specified complications of surgical and medical care, not elsewhere classified
0.000 0.995 0.005
M96.8 Other postprocedural musculoskeletal disorders
0.004 0.996 0.000
M96.0 Pseudarthrosis after fusion or arthrodesis
0.004 0.996 0.000
J44 Other chronic obstructive pulmonary disease
0.000 0.996 0.004
K40.2 Bilateral inguinal hernia, without obstruction or gangrene
0.004 0.996 0.000
T88.5 Other complications of anaesthesia
0.000 0.996 0.004
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.004 0.996 0.000
C83.0 Small cell (diffuse)
0.004 0.996 0.000
T88.4 Failed or difficult intubation
0.000 0.996 0.004
G99.2 Myelopathy in diseases classified elsewhere
0.000 0.996 0.004
J95.0 Tracheostomy malfunction
0.000 0.996 0.004
R68.3 Clubbing of fingers
0.004 0.996 0.000
C83.6 Undifferentiated (diffuse)
0.004 0.996 0.000
C83.5 Lymphoblastic (diffuse)
0.004 0.996 0.000
C83.4 Immunoblastic (diffuse)
0.004 0.996 0.000
C83.2 Mixed small and large cell (diffuse)
0.004 0.996 0.000
T88.7 Unspecified adverse effect of drug or medicament
0.000 0.996 0.004
M96 Postprocedural musculoskeletal disorders, not elsewhere classified
0.004 0.996 0.000
R68.1 Nonspecific symptoms peculiar to infancy
0.004 0.996 0.000
J43 Emphysema
0.000 0.996 0.004
I69.3 Sequelae of cerebral infarction
0.004 0.996 0.000
C83.7 Burkitt's tumour
0.004 0.996 0.000
T88.9 Complication of surgical and medical care, unspecified
0.000 0.996 0.004
O82 Single delivery by Caesarean section
0.004 0.996 0.000
T88.3 Malignant hyperthermia due to anaesthesis
0.000 0.996 0.003
T88.1 Other complications following immunisation, not elsewhere classified
0.000 0.996 0.003
T88.0 Infection following immunisation
0.000 0.996 0.003
T88.2 Shock due to anaesthesia
0.000 0.997 0.003
F20.0 Paranoid schizophrenia
0.003 0.997 0.000
J43.2 Centrilobular emphysema
0.000 0.997 0.003
M96.9 Postprocedural musculoskeletal disorder, unspecified
0.003 0.997 0.000
J43.8 Other emphysema
0.000 0.997 0.003
Y40.0 Penicillins
0.000 0.997 0.003
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites
0.003 0.997 0.000
D47.3 Essential (haemorrhagic) thrombocythaemia
0.000 0.997 0.003
M96.1 Postlaminectomy syndrome, not elsewhere classified
0.003 0.997 0.000
R68.0 Hypothermia, not associated with low environmental temperature
0.003 0.997 0.000
O82.9 Delivery by Caesarean section, unspecified
0.003 0.997 0.000
M67.1 Other contracture of tendon (sheath)
0.003 0.997 0.000
M96.6 Fracture of bone following insertion of orthopaedic implant, joint prosthesis or bone plate
0.003 0.997 0.000
M96.5 Postradiation scoliosis
0.003 0.997 0.000
M96.4 Postsurgical lordosis
0.003 0.997 0.000
M96.3 Postlaminectomy kyphosis
0.003 0.997 0.000
M96.2 Postradiation kyphosis
0.003 0.997 0.000
Z40.0 Prophylactic surgery for risk-factors related to malignant neoplasms
0.003 0.997 0.000
J43.1 Panlobular emphysema
0.000 0.997 0.003
J43.0 MacLeod's syndrome
0.000 0.997 0.003
R30.9 Painful micturition, unspecified
0.000 0.997 0.003
O82.8 Other single delivery by Caesarean section
0.003 0.997 0.000
O82.2 Delivery by Caesarean hysterectomy
0.003 0.997 0.000
W19.2 School, other institution and public administrative area
0.000 0.997 0.003
M46.92 Inflammatory spondylopathy, unspecified (Cervical region)
0.000 0.997 0.003
D47.4 Osteomyelofibrosis
0.000 0.997 0.003
D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
0.000 0.997 0.003
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.003 0.997 0.000
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
0.000 0.997 0.003
B16.9 Acute hepatitis B without delta-agent and without hepatic coma
0.003 0.997 0.000
J33.8 Other polyp of sinus
0.003 0.997 0.000
R30.0 Dysuria
0.000 0.997 0.003
K09.2 Other cysts of jaw
0.000 0.997 0.003
K40.0 Bilateral inguinal hernia, with obstruction, without gangrene
0.003 0.997 0.000
M96.65 Fracture of pelvis following insertion of orthopedic implant, joint prosthesis, or bone plate (Fx pelvis following insrt ortho implnt/prosth/bone plt)
0.002 0.997 0.000
M96.63 Fracture of radius or ulna following insertion of orthopedic implant, joint prosthesis, or bone plate
0.002 0.997 0.000
C76 Malignant neoplasm of other and ill-defined sites
0.002 0.997 0.000
O82.1 Delivery by emergency Caesarean section
0.002 0.997 0.000
K40.3 Unilateral or unspecified inguinal hernia, with obstruction, without gangrene
0.003 0.997 0.000
K40 Inguinal hernia
0.003 0.997 0.000
C76.0 Head, face and neck
0.002 0.998 0.000
C80 Malignant neoplasm without specification of site
0.002 0.998 0.000
G99 Other disorders of nervous system in diseases classified elsewhere
0.000 0.998 0.002
C77.5 Intrapelvic lymph nodes
0.002 0.998 0.000
D37.5 Rectum
0.000 0.998 0.002
G99.0 Autonomic neuropathy in endocrine and metabolic diseases
0.000 0.998 0.002
Z29.2 Other prophylactic chemotherapy
0.002 0.998 0.000
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified
0.000 0.998 0.002
D47.7 Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
0.000 0.998 0.002
D47.5 Chronic eosinophilic leukaemia [hypereosinophilic syndrome]
0.000 0.998 0.002
D47.0 Histiocytic and mast cell tumours of uncertain and unknown behaviour
0.000 0.998 0.002
I12.0 Hypertensive renal disease with renal failure
0.000 0.998 0.002
J35.1 Hypertrophy of tonsils
0.002 0.998 0.000
R30 Pain associated with micturition
0.000 0.998 0.002
M54.56 Low back pain (Lumbar region)
0.000 0.998 0.002
O61.0 Failed medical induction of labour
0.000 0.998 0.002
F23.0 Acute polymorphic psychotic disorder without symptoms of schizophrenia
0.002 0.998 0.000
F20 Schizophrenia
0.002 0.998 0.000
C76.8 Overlapping lesion of other and ill-defined sites
0.002 0.998 0.000
C76.7 Other ill-defined sites
0.002 0.998 0.000
C76.5 Lower limb
0.002 0.998 0.000
C76.4 Upper limb
0.002 0.998 0.000
M77.47 Metatarsalgia-Ankle/Foot
0.002 0.998 0.000
K40.4 Unilateral or unspecified inguinal hernia, with gangrene
0.002 0.998 0.000
K40.1 Bilateral inguinal hernia, with gangrene
0.002 0.998 0.000
F23.9 Acute and transient psychotic disorder, unspecified
0.002 0.998 0.000
C76.1 Thorax
0.002 0.998 0.000
D47.2 Monoclonal gammopathy
0.000 0.998 0.002
Z74.0 Reduced mobility
0.000 0.998 0.002
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system
0.002 0.998 0.000
C80.0 Malignant neoplasm, primary site unknown, so stated
0.002 0.998 0.000
M46.96 Inflammatory spondylopathy, unspecified (Lumbar region)
0.000 0.998 0.002
C76.2 Abdomen
0.002 0.998 0.000
G99.8 Other specified disorders of nervous system in diseases classified elsewhere
0.000 0.998 0.002
G99.1 Other disorders of autonomic nervous system in other diseases classified elsewhere
0.000 0.998 0.002
F23 Acute and transient psychotic disorders
0.002 0.998 0.000
D37.6 Liver, gallbladder and bile ducts
0.000 0.998 0.002
K09 Cysts of oral region, not elsewhere classified
0.000 0.998 0.002
D06.9 Cervix, unspecified
0.000 0.998 0.002
F20.2 Catatonic schizophrenia
0.002 0.998 0.000
K09.9 Cyst of oral region, unspecified
0.000 0.998 0.002
L73.2 Hidradenitis suppurativa
0.002 0.998 0.000
M48.02 Spinal stenosis (Cervical region)
0.000 0.998 0.002
M23.26 Derangement of meniscus due to old tear or injury (Other and unspecified lateral meniscus)
0.000 0.998 0.002
C79.5 Secondary malignant neoplasm of bone and bone marrow
0.002 0.998 0.000
M46.9 Inflammatory spondylopathy, unspecified
0.000 0.998 0.002
Z21 Asymptomatic human immunodeficiency virus [HIV] infection status
0.002 0.998 0.000
K09.0 Developmental odontogenic cysts
0.000 0.998 0.002
Y40.1 Cefalosporins and other -lactam antibiotics
0.000 0.998 0.002
J40 Bronchitis, not specified as acute or chronic
0.000 0.998 0.002
C92.1 Chronic myeloid leukaemia
0.000 0.998 0.002
K09.8 Other cysts of oral region, not elsewhere classified
0.000 0.998 0.002
J40-J47 Chronic lower respiratory diseases
0.000 0.998 0.002
M45.X0 Ankylosing spondylitis (Multiple sites in spine)
0.000 0.998 0.002
F20.8 Other schizophrenia
0.002 0.998 0.000
F20.6 Simple schizophrenia
0.002 0.998 0.000
F20.5 Residual schizophrenia
0.002 0.998 0.000
F20.4 Postschizophrenic depression
0.002 0.998 0.000
F20.3 Undifferentiated schizophrenia
0.002 0.998 0.000
F20.1 Hebephrenic schizophrenia
0.002 0.998 0.000
F25.1 Schizoaffective disorder, depressive type
0.002 0.998 0.000
C80.9 Malignant neoplasm, unspecified
0.002 0.998 0.000
N20.1 Calculus of ureter
0.002 0.998 0.000
Z20.8 Contact with and exposure to other communicable diseases
0.002 0.998 0.000
I38 Endocarditis, valve unspecified
0.002 0.998 0.000
M46.97 Inflammatory spondylopathy, unspecified (Lumbosacral region)
0.000 0.998 0.002
J20.9 Acute bronchitis, unspecified
0.000 0.998 0.002
K01.1 Impacted teeth
0.000 0.998 0.002
J35.2 Hypertrophy of adenoids
0.002 0.998 0.000
R30.1 Vesical tenesmus
0.000 0.998 0.002
K09.1 Developmental (nonodontogenic) cysts of oral region
0.000 0.998 0.002
S61.8 Open wound of other parts of wrist and hand
0.002 0.998 0.000
M46.90 Inflammatory spondylopathy, unspecified (Multiple sites in spine)
0.000 0.998 0.002
M79.86 Other specified soft tissue disorders (Lower leg)
0.002 0.998 0.000
D38.1 Trachea, bronchus and lung
0.000 0.998 0.002
F23.8 Other acute and transient psychotic disorders
0.002 0.998 0.000
F23.3 Other acute predominantly delusional psychotic disorders
0.002 0.998 0.000
F23.2 Acute schizophrenia-like psychotic disorder
0.002 0.998 0.000
F23.1 Acute polymorphic psychotic disorder with symptoms of schizophrenia
0.002 0.998 0.000
M50.0 Cervical disk disorder with myelopathy
0.000 0.998 0.002
D47.1 Chronic myeloproliferative disease
0.000 0.998 0.002
Y52.3 Coronary vasodilators, not elsewhere classified
0.000 0.998 0.002
C76.3 Pelvis
0.001 0.998 0.001
D37.3 Appendix
0.000 0.998 0.002
E21.0 Primary hyperparathyroidism
0.000 0.998 0.002
C79 Secondary malignant neoplasm of other sites
0.002 0.998 0.000
S82.00 Fracture of patella (closed)
0.002 0.998 0.000
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs
0.000 0.998 0.002
M46.95 Inflammatory spondylopathy, unspecified (Thoracolumbar region)
0.000 0.998 0.001
M46.94 Inflammatory spondylopathy, unspecified (Thoracic region)
0.000 0.998 0.001
M46.93 Inflammatory spondylopathy, unspecified (Cervicothoracic region)
0.000 0.998 0.001
M46.91 Inflammatory spondylopathy, unspecified (Occipito-atlanto-axial region)
0.000 0.998 0.001
C79.2 Secondary malignant neoplasm of skin
0.002 0.998 0.000
I33.0 Acute and subacute infective endocarditis
0.002 0.998 0.000
J41 Simple and mucopurulent chronic bronchitis
0.000 0.998 0.002
F25 Schizoaffective disorders
0.002 0.998 0.000
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs
0.002 0.998 0.000
E22.0 Acromegaly and pituitary gigantism
0.000 0.998 0.001
L05.0 Pilonidal cyst with abscess
0.000 0.998 0.002
M46.98 Inflammatory spondylopathy, unspecified (Sacral and sacrococcygeal region)
0.000 0.998 0.001
M87.25 Osteonecrosis due to previous trauma (Pelvic region and thigh)
0.001 0.998 0.000
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs
0.000 0.998 0.002
Z20 Contact with and exposure to communicable diseases
0.001 0.998 0.000
D40.0 Prostate
0.000 0.998 0.001
F20-F29 Schizophrenia, schizotypal and delusional disorders
0.002 0.998 0.000
D18.1 Lymphangioma, any site
0.001 0.998 0.000
S66.2 Injury of extensor muscle and tendon of thumb at wrist and hand level
0.000 0.998 0.001
D37.1 Stomach
0.000 0.998 0.001
B16 Acute hepatitis B
0.001 0.998 0.000
J41.0 Simple chronic bronchitis
0.000 0.999 0.001
D38.0 Larynx
0.000 0.999 0.001
Z29 Need for other prophylactic measures
0.001 0.999 0.000
C77.8 Lymph nodes of multiple regions
0.001 0.999 0.000
E10.1 With ketoacidosis
0.000 0.999 0.001
J35.9 Chronic disease of tonsils and adenoids, unspecified
0.001 0.999 0.000
J41.8 Mixed simple and mucopurulent chronic bronchitis
0.000 0.999 0.001
J41.1 Mucopurulent chronic bronchitis
0.000 0.999 0.001
J35 Chronic diseases of tonsils and adenoids
0.001 0.999 0.000
D37.9 Digestive organ, unspecified
0.000 0.999 0.001
D44.0 Thyroid gland
0.000 0.999 0.001
F25.9 Schizoaffective disorder, unspecified
0.001 0.999 0.000
F25.8 Other schizoaffective disorders
0.001 0.999 0.000
F25.2 Schizoaffective disorder, mixed type
0.001 0.999 0.000
N90.7 Vulvar cyst
0.001 0.999 0.000
S10.9 Superficial injury of neck, part unspecified
0.000 0.999 0.001
K83 Other diseases of biliary tract
0.000 0.999 0.001
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.001 0.999 0.000
D40 Neoplasm of uncertain or unknown behaviour of male genital organs
0.000 0.999 0.001
A15.2 Tuberculosis of lung, confirmed histologically
0.001 0.999 0.000
D38.6 Respiratory organ, unspecified
0.000 0.999 0.001
D38.5 Other respiratory organs
0.000 0.999 0.001
D38.4 Thymus
0.000 0.999 0.001
D38.3 Mediastinum
0.000 0.999 0.001
D38.2 Pleura
0.000 0.999 0.001
M54.3 Sciatica
0.001 0.999 0.000
Z20.9 Contact with and exposure to unspecified communicable disease
0.001 0.999 0.000
Z20.7 Contact with and exposure to pediculosis, acariasis and other infestations
0.001 0.999 0.000
Z20.6 Contact with and exposure to human immunodeficiency virus [HIV]
0.001 0.999 0.000
Z20.5 Contact with and exposure to viral hepatitis
0.001 0.999 0.000
Z20.4 Contact with and exposure to rubella
0.001 0.999 0.000
Z20.3 Contact with and exposure to rabies
0.001 0.999 0.000
Z20.2 Contact with and exposure to infections with a predominantly sexual mode of transmission
0.001 0.999 0.000
Z20.1 Contact with and exposure to tuberculosis
0.001 0.999 0.000
Z20.0 Contact with and exposure to intestinal infectious diseases
0.001 0.999 0.000
Z29.0 Isolation
0.001 0.999 0.000
C55 Malignant neoplasm of uterus, part unspecified
0.000 0.999 0.001
O72 Postpartum haemorrhage
0.001 0.999 0.000
R40.2 Coma, unspecified
0.000 0.999 0.001
F28 Other nonorganic psychotic disorders
0.001 0.999 0.000
F24 Induced delusional disorder
0.001 0.999 0.000
F21 Schizotypal disorder
0.001 0.999 0.000
B16.2 Acute hepatitis B without delta-agent with hepatic coma
0.001 0.999 0.000
B16.1 Acute hepatitis B with delta-agent (coinfection) without hepatic coma
0.001 0.999 0.000
B16.0 Acute hepatitis B with delta-agent (coinfection) with hepatic coma
0.001 0.999 0.000
U80.1 Methicillin resistant agent
0.001 0.999 0.000
N41.1 Chronic prostatitis
0.000 0.999 0.001
X47.0 Home
0.001 0.999 0.000
Z04.3 Examination and observation following other accident
0.000 0.999 0.001
F25.0 Schizoaffective disorder, manic type
0.001 0.999 0.000
J35.3 Hypertrophy of tonsils with hypertrophy of adenoids
0.001 0.999 0.000
K75.8 Other specified inflammatory liver diseases
0.000 0.999 0.001
K83.4 Spasm of sphincter of Oddi
0.000 0.999 0.001
K83.3 Fistula of bile duct
0.000 0.999 0.001
M45.X2 Ankylosing spondylitis (Cervical region)
0.000 0.999 0.001
Z29.9 Prophylactic measure, unspecified
0.001 0.999 0.000
R14 Flatulence and related conditions
0.000 0.999 0.001
Z20-Z29 Persons with potential health hazards related to communicable diseases
0.001 0.999 0.000
J95-J99 Other diseases of the respiratory system
0.000 0.999 0.001
J35.8 Other chronic diseases of tonsils and adenoids
0.001 0.999 0.000
K83.5 Biliary cyst
0.000 0.999 0.001
K83.2 Perforation of bile duct
0.000 0.999 0.001
M77.4 Metatarsalgia
0.001 0.999 0.000
M54.35 Sciatica (Thoracolumbar region)
0.001 0.999 0.000
M54.34 Sciatica-Thoracic
0.001 0.999 0.000
M54.33 Sciatica-Cervicothoracic
0.001 0.999 0.000
M54.32 Sciatica-Cervical
0.001 0.999 0.000
M54.31 Sciatica-Occipit-atl-axl
0.001 0.999 0.000
M54.30 Sciatica (Multiple sites in spine)
0.001 0.999 0.000
D40.9 Male genital organ, unspecified
0.000 0.999 0.001
D40.7 Other male genital organs
0.000 0.999 0.001
D40.1 Testis
0.000 0.999 0.001
D44.3 Pituitary gland
0.000 0.999 0.001
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands
0.000 0.999 0.001
M77.97 Enthesopathy, unspecified (Ankle and foot)
0.001 0.999 0.000
M81.20 Osteoporosis of disuse (Multiple sites)
0.000 0.999 0.001
M87.98 Osteonecrosis, unspecified (Other)
0.001 0.999 0.000
C79.6 Secondary malignant neoplasm of ovary
0.001 0.999 0.000
C79.0 Secondary malignant neoplasm of kidney and renal pelvis
0.001 0.999 0.000
D44.4 Craniopharyngeal duct
0.000 0.999 0.001
F60.9 Personality disorder, unspecified
0.000 0.999 0.001
F60.3 Emotionally unstable personality disorder
0.000 0.999 0.001
M87.2 Osteonecrosis due to previous trauma
0.001 0.999 0.000
O72.3 Postpartum coagulation defects
0.001 0.999 0.000
Z54.0 Convalescence following surgery
0.001 0.999 0.000
C79.3 Secondary malignant neoplasm of brain and cerebral meninges
0.001 0.999 0.000
D37.7 Other digestive organs
0.000 0.999 0.001
H27.8 Other specified disorders of lens
0.000 0.999 0.001
Z80.1 Family history of malignant neoplasm of trachea, bronchus and lung
0.000 0.999 0.001
D37-D48 Neoplasms of uncertain or unknown behaviour
0.000 0.999 0.001
M60.08 Infective myositis (Other)
0.001 0.999 0.000
D46.2 Refractory anaemia with excess of blasts
0.000 0.999 0.001
M87.27 Osteonecrosis due to previous trauma (Ankle and foot)
0.001 0.999 0.000
M87.95 Osteonecrosis, unspecified (Pelvic region and thigh)
0.001 0.999 0.000
D39.1 Ovary
0.000 0.999 0.001
K41.3 Unilateral or unspecified femoral hernia, with obstruction, without gangrene
0.001 0.999 0.000
D39 Neoplasm of uncertain or unknown behaviour of female genital organs
0.000 0.999 0.001
J96 Respiratory failure, not elsewhere classified
0.000 0.999 0.001
Y40 Systemic antibiotics
0.000 0.999 0.001
Z28 Immunisation not carried out
0.001 0.999 0.000
Z27 Need for immunisation against combinations of infectious diseases
0.001 0.999 0.000
Z26 Need for immunisation against other single infectious diseases
0.001 0.999 0.000
Z25 Need for immunisation against other single viral diseases
0.001 0.999 0.000
Z23 Need for immunisation against single bacterial diseases
0.001 0.999 0.000
M54.38 Sciatica (Sacral and sacrococcygeal region)
0.001 0.999 0.000
M77.49 Metatarsalgia-Site unspec
0.001 0.999 0.000
M77.48 Metatarsalgia-Other
0.001 0.999 0.000
M77.46 Metatarsalgia-Lower Leg
0.001 0.999 0.000
M77.45 Metatarsalgia-Pelvic/Thigh
0.001 0.999 0.000
M77.44 Metatarsalgia-Hand
0.001 0.999 0.000
M77.43 Metatarsalgia-Forearm
0.001 0.999 0.000
M77.42 Metatarsalgia-Upper arm
0.001 0.999 0.000
M77.41 Metatarsalgia-Shldr region
0.001 0.999 0.000
M77.40 Metatarsalgia-Mult sites
0.001 0.999 0.000
S42.31 Fracture of shaft of humerus (open)
0.001 0.999 0.000
D44.6 Carotid body
0.000 0.999 0.001
D44.5 Pineal gland
0.000 0.999 0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.